The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis

Completed

• Conditions: Tuberculosis

• Registration Number: NCT00982969
• Lead Sponsor: Armed Forces Capital Hospital, Republic of Korea

Brief Summary

The investigators will evaluate the usefulness of QuantiFERON-TB Gold in-tube (QFT) in the diagnosis of active tuberculosis in young adults group, highly clinically suspected tuberculosis.

Detailed Description

Investigators will enroll prospectively all clinically and radiologically suspected tuberculosis patients from 20 to 29 years old who visited the Armed Forces Capital Hospital. Investigators will perform QFT and tuberculin skin test. Diagnosis of tuberculosis will be made by World Health Organization guideline and the physician will not know the QuantiFERON-TB Gold in-tube results before the diagnosis and anti-tuberculosis medication. Investigators will evaluate the sensitivity and specificity of QuantiFERON-TB Gold in-tube in the diagnosis of active tuberculosis among young adults.

Study Timeline

• Study Start: 2008-06
• Status Verified: 2009-09
• Study First Submitted: 2009-09-22
• Study First Submitted QC: 2009-09-22
• Study First Posted: 2009-09-23
• Primary Completion: 2009-10
• Study Completion: 2010-04
• Last Update Submitted: 2010-07-19
• Last Update Posted: 2010-07-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 200

Inclusion Criteria

• All clinically and radiologically suspected TB patients from 20 to 29 years old who visited the Armed Forces Capital Hospital

Exclusion Criteria

• Soldiers who do not agree with study protocol

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Armed Forces Capital Hospital; 🇰🇷 Seongnam-si, Gyeonggi-do, Korea, Republic of